The control of reactive oxygen species production by SHP-1 in oligodendrocytes

GLIA

Volumn 63, Issue 10, 2015, Pages 1753-1771

  Gruber, Ross C ^a,b   Larocca, Daria ^a   Minchenberg, Scott B ^a   Christophi, George P ^a,c   Hudson, Chad A ^a,d   Ray, Alex K ^b   Shafit Zagardo, Bridget ^b   Massa, Paul T ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Inflammation; Multiple sclerosis; Myelin; Normal appearing white matter; Oxidative stress

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BETA ACTIN; GAMMA INTERFERON; GLUTATHIONE; HEME OXYGENASE 1; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALTOSE BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PROTEIN TYROSINE PHOSPHATASE SHP 1; PROTEOLIPID PROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR NRF2; TRANSCRIPTION FACTOR SOX10; CYTOKINE; DNA BINDING PROTEIN; MYELIN PROTEIN; PTPN6 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; GLIA; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID PEROXIDATION; MALE; MOUSE; MULTIPLE SCLEROSIS; MYELIN DEFICIENCY; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE CELL LESION; NONHUMAN; OLIGODENDROGLIA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CARBONYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; CELL CULTURE; CENTRAL NERVOUS SYSTEM; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEWBORN; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CYTOKINES; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; MICE; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; MYELIN PROTEINS; NF-KAPPA B; OLIGODENDROGLIA; PROTEIN CARBONYLATION; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 6; REACTIVE OXYGEN SPECIES;

EID: 84938957037     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22842     Document Type: Article

References (72)

1. Anrather J, Racchumi G, Iadecola C. 2006. NF-kappaB regulates phagocytic NADPH oxidase by inducing the expression of gp91phox. J Biol Chem 281:5657-5667.
2. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. 1998. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci 18:6241-6253.
3. Berlett BS, Stadtman ER. 1997. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272:20313-20316.
4. Cammer W. 2002. Protection of cultured oligodendrocytes against tumor necrosis factor-alpha by the antioxidants coenzyme Q(10) and N-acetyl cysteine. Brain Res Bull 58:587-592.
5. Cammer W, Zhang H. 1999. Maturation of oligodendrocytes is more sensitive to TNF alpha than is survival of precursors and immature oligodendrocytes. J Neuroimmunol 97:37-42.
6. Cannella B, Raine CS. 2004. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 55:46-57.
7. Carson JH, Nielson ML, Barbarese E. 1983. Developmental regulation of myelin basic protein expression in mouse brain. Dev Biol 96:485-492.
8. Chou WC, Chen HY, Yu SL, Cheng L, Yang PC, Dang CV. 2005. Arsenic suppresses gene expression in promyelocytic leukemia cells partly through sp1 oxidation. Blood 106:304-310.
9. Christophi GP, Hudson CA, Gruber R, Christophi CP, Massa PT. 2008a. Promoter-specific induction of the phosphatase SHP-1 by viral infection and cytokines in CNS glia. J Neurochem 105:2511-2523.
10. Christophi GP, Hudson CA, Gruber RC, Christophi CP, Mihai C, Mejico LJ, Jubelt B, Massa PT. 2008b. SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients. Lab Invest 88:243-255.
11. Christophi GP, Panos M, Hudson CA, Christophi RL, Gruber RC, Mersich AT, Blystone SD, Jubelt B, Massa PT. 2009. Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype. Lab Invest 89:742-759.
12. Connor JR, Menzies SL. 1996. Relationship of iron to oligodendrocytes and myelination. Glia 17:83-93.
13. Dasgupta A, Zheng J, Perrone-Bizzozero NI, Bizzozero OA. 2013. Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis. ASN Neuro 5:e00111.
14. Deng C, Minguela A, Hussain RZ, Lovett-Racke AE, Radu C, Ward ES, Racke MK. 2002. Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis. J Immunol 168:4511-4518.
15. Druzhyna NM, Hollensworth SB, Kelley MR, Wilson GL, Ledoux SP. 2003. Targeting human 8-oxoguanine glycosylase to mitochondria of oligodendrocytes protects against menadione-induced oxidative stress. Glia 42:370-378. [PMC][10.1002/glia.10230] [12730957]21
16. Feng X, Petraglia AL, Chen M, Byskosh PV, Boos MD, Reder AT. 2002. Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of stat1. J Neuroimmunol 129:205-215.
17. French HM, Reid M, Mamontov P, Simmons RA, Grinspan JB. 2009. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res 87:3076-3087.
18. Gloire G, Legrand-Poels S, Piette J. 2006. NF-kappaB activation by reactive oxygen species: Fifteen years later. Biochem Pharmacol 72:1493-1505.
19. Goujet-Zalc C, Babinet C, Monge M, Timsit S, Cabon F, Gansmuller A, Miura M, Sanchez M, Pournin S, Mikoshiba K, Zalc B. 1993. The proximal region of the MBP gene promoter is sufficient to induce oligodendroglial-specific expression in transgenic mice. Eur J Neurosci 5:624-632.
20. Green MC, Shultz LD. 1975. Motheaten, an immunodeficient mutant of the mouse. I. Genetics and pathology. J Hered 66:250-258.
21. Hudson CA, Christophi GP, Gruber RC, Wilmore JR, Lawrence DA, Massa PT. 2008. Induction of IL-33 expression and activity in central nervous system glia. J Leukoc Biol 84:631-643.
22. Jana M, Pahan K. 2005. Redox regulation of cytokine-mediated inhibition of myelin gene expression in human primary oligodendrocytes. Free Radic Biol Med 39:823-831.
23. Janz R, Stoffel W. 1993. Characterization of a brain-specific Sp1-like activity interacting with an unusual binding site within the myelin proteolipid protein promoter. Biol Chem Hoppe Seyler 374:507-517.
24. Johnstone JT, Morton PD, Jayakumar AR, Johnstone AL, Gao H, Bracchi-Ricard V, Pearse DD, Norenberg MD, Bethea JR. 2013. Inhibition of NADPH oxidase activation in oligodendrocytes reduces cytotoxicity following trauma. PLoS One 8:e80975.
25. Juurlink BH, Thorburne SK, Hertz L. 1998. Peroxide-scavenging deficit underlies oligodendrocyte susceptibility to oxidative stress. Glia 22:371-378.
26. Kamata H, Honda S, Maeda S, Chang L, Hirata H, Karin M. 2005. Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120:649-661.
27. Kohen R, Nyska A. 2002. Oxidation of biological systems: Oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol Pathol 30:620-650.
28. Krotz F, Engelbrecht B, Buerkle MA, Bassermann F, Bridell H, Gloe T, Duyster J, Pohl U, Sohn HY. 2005. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. J Am Coll Cardiol 45:1700-1706.
29. Kumagai C, Kalman B, Middleton FA, Vyshkina T, Massa PT. 2012. Increased promoter methylation of the immune regulatory gene SHP-1 in leukocytes of multiple sclerosis subjects. J Neuroimmunol 246:51-57.
30. Kuo E, Park DK, Tzvetanova ID, Leiton CV, Cho BS, Colognato H. 2010. Tyrosine phosphatases shp1 and shp2 have unique and opposing roles in oligodendrocyte development. J Neurochem 113:200-212.
31. Liu Q, Berchner-Pfannschmidt U, Moller U, Brecht M, Wotzlaw C, Acker H, Jungermann K, Kietzmann T. 2004. A fenton reaction at the endoplasmic reticulum is involved in the redox control of hypoxia-inducible gene expression. Proc Natl Acad Sci U S A 101:4302-4307.
32. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods 25:402-408.
33. Lyons BL, Lynes MA, Burzenski L, Joliat MJ, Hadjout N, Shultz LD. 2003. Mechanisms of anemia in SHP-1 protein tyrosine phosphatase-deficient "viable motheaten" mice. Exp Hematol 31:234-243.
34. Mandal D, Fu P, Levine AD. 2010. REDOX regulation of IL-13 signaling in intestinal epithelial cells: Usage of alternate pathways mediates distinct gene expression patterns. Cell Signal 22:1485-1494.
35. Mariappan N, Elks CM, Sriramula S, Guggilam A, Liu Z, Borkhsenious O, Francis J. 2010. NF-kappaB-induced oxidative stress contributes to mitochondrial and cardiac dysfunction in type II diabetes. Cardiovasc Res 85:473-483.
36. Massa PT, Ropka SL, Saha S, Fecenko KL, Beuler KL. 2002. Critical role for protein tyrosine phosphatase SHP-1 in controlling infection of central nervous system glia and demyelination by Theiler's murine encephalomyelitis virus. J Virol 76:8335-8346.
37. Massa PT, Saha S, Wu C, Jarosinski KW. 2000. Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes. Glia 29:376-385.
38. Massa PT, Wu C. 1998. Increased inducible activation of NF-kappaB and responsive genes in astrocytes deficient in the protein tyrosine phosphatase SHP-1. J Interferon Cytokine Res 18:499-507.
39. Massa PT, Wu C, Fecenko-Tacka K. 2004. Dysmyelination and reduced myelin basic protein gene expression by oligodendrocytes of SHP-1-deficient mice. J Neurosci Res 77:15-25.
40. Mc Guire C, Prinz M, Beyaert R, van Loo G. 2013. Nuclear factor kappa B (NF-kappaB) in multiple sclerosis pathology. Trends Mol Med 19:604-613.
41. McTigue DM, Tripathi RB. 2008. The life, death, and replacement of oligodendrocytes in the adult CNS. J Neurochem 107:1-19.
42. Meng TC, Fukada T, Tonks NK. 2002. Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Mol Cell 9:387-399.
43. Mir M, Asensio VJ, Tolosa L, Gou-Fabregas M, Soler RM, Llado J, Olmos G. 2009. Tumor necrosis factor alpha and interferon gamma cooperatively induce oxidative stress and motoneuron death in rat spinal cord embryonic explants. Neuroscience 162:959-971.
44. 2 via stat6 phosphorylation, resulting in cyclooxygenase-2 expression and prostaglandin release. J Immunol 188:5132-5141.
45. Peirano RI, Wegner M. 2000. The glial transcription factor sox10 binds to DNA both as monomer and dimer with different functional consequences. Nucleic Acids Res 28:3047-3055.
46. Reich NC. 2009. Stat3 revs up the powerhouse. Sci Signal 2:pe61.
47. Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. 2010. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med 49:1603-1616.
48. Sarafian TA, Montes C, Imura T, Qi J, Coppola G, Geschwind DH, Sofroniew MV. 2010. Disruption of astrocyte stat3 signaling decreases mitochondrial function and increases oxidative stress in vitro. PLoS One 5:e9532.
49. Schreck R, Rieber P, Baeuerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258.
50. Sharma P, Chakraborty R, Wang L, Min B, Tremblay ML, Kawahara T, Lambeth JD, Haque SJ. 2008. Redox regulation of interleukin-4 signaling. Immunity 29:551-564.
51. Shulga N, Pastorino JG. 2012. GRIM-19-mediated translocation of stat3 to mitochondria is necessary for TNF-induced necroptosis. J Cell Sci 125:2995-3003.
52. Shultz LD, Green MC. 1976. Motheaten, an immunodeficient mutant of the mouse. II. Depressed immune competence and elevated serum immunoglobulins. J Immunol 116:936-943.
53. Sidman CL, Shultz LD, Unanue ER. 1978. The mouse mutant "motheaten." II. Functional studies of the immune system. J Immunol 121:2399-2404.
54. Simon AR, Rai U, Fanburg BL, Cochran BH. 1998. Activation of the JAK-STAT pathway by reactive oxygen species. Am J Physiol 275:C1640-C1652.
55. Smith KJ, Kapoor R, Felts PA. 1999. Demyelination: The role of reactive oxygen and nitrogen species. Brain Pathol 9:69-92.
56. Takada Y, Mukhopadhyay A, Kundu GC, Mahabeleshwar GH, Singh S, Aggarwal BB. 2003. Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: Evidence for the involvement of I kappa B alpha kinase and syk protein-tyrosine kinase. J Biol Chem 278:24233-24241.
57. Tamura T, Aoyama A, Inoue T, Miura M, Okano H, Mikoshiba K. 1989. Tissue-specific in vitro transcription from the mouse myelin basic protein promoter. Mol Cell Biol 9:3122-3126.
58. Thorburne SK, Juurlink BH. 1996. Low glutathione and high iron govern the susceptibility of oligodendroglial precursors to oxidative stress. J Neurochem 67:1014-1022.
59. Tonks NK. 2005. Redox redux: Revisiting PTPs and the control of cell signaling. Cell 121:667-670.
60. Tretiakova A, Steplewski A, Johnson EM, Khalili K, Amini S. 1999. Regulation of myelin basic protein gene transcription by sp1 and puralpha: Evidence for association of sp1 and puralpha in brain. J Cell Physiol 181:160-168.
61. Tully M, Shi R. 2013. New insights in the pathogenesis of multiple sclerosis-role of acrolein in neuronal and myelin damage. Int J Mol Sci 14:20037-20047.
62. Uchida K. 1999. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9:109-113.
63. van der Goes A, Brouwer J, Hoekstra K, Roos D, van den Berg TK, Dijkstra CD. 1998. Reactive oxygen species are required for the phagocytosis of myelin by macrophages. J Neuroimmunol 92:67-75.
64. Verity AN, Bredesen D, Vonderscher C, Handley VW, Campagnoni AT. 1993. Expression of myelin protein genes and other myelin components in an oligodendrocytic cell line conditionally immortalized with a temperature-sensitive retrovirus. J Neurochem 60:577-587.
65. Wang X, Seed B. 2003. A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res 31:e154.
66. Wegrzyn J, Potla R, Chwae YJ, Sepuri NB, Zhang Q, Koeck T, Derecka M, Szczepanek K, Szelag M, Gornicka A, Moh A, Moghaddas S, Chen Q, Bobbili S, Cichy J, Dulak J, Baker DP, Wolfman A, Stuehr D, Hassan MO, Fu XY, Avadhani N, Drake JI, Fawcett P, Lesnefsky EJ, Larner AC. 2009. Function of mitochondrial stat3 in cellular respiration. Science 323:793-797.
67. Wei Q, Miskimins WK, Miskimins R. 2004. Sox10 acts as a tissue-specific transcription factor enhancing activation of the myelin basic protein gene promoter by p27kip1 and sp1. J Neurosci Res 78:796-802.
68. Welch KD, Davis TZ, Van Eden ME, Aust SD. 2002. Deleterious iron-mediated oxidation of biomolecules. Free Radic Biol Med 32:577-583.
69. Wishcamper CA, Coffin JD, Lurie DI. 2001. Lack of the protein tyrosine phosphatase SHP-1 results in decreased numbers of glia within the motheaten (me/me) mouse brain. J Comp Neurol 441:118-133.
70. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. 2008. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 131:288-303.
71. Zhang J, Zhang Y, Dutta DJ, Argaw AT, Bonnamain V, Seto J, Braun DA, Zameer A, Hayot F, Lopez CB, Raine CS, John GR. 2011. Proapoptotic and antiapoptotic actions of stat1 versus stat3 underlie neuroprotective and immunoregulatory functions of IL-11. J Immunol 187:1129-1141.
72. Ziabreva I, Campbell G, Rist J, Zambonin J, Rorbach J, Wydro MM, Lassmann H, Franklin RJ, Mahad D. 2010. Injury and differentiation following inhibition of mitochondrial respiratory chain complex IV in rat oligodendrocytes. Glia 58:1827-1837.